Financial News Systems delivers millisecond‑level market news alerts for over 9,000 publicly traded companies across the U.S., Europe, and Canada. Its AI engine extracts key financial metrics, compares results to FactSet estimates, and provides concise summaries, enabling portfolio managers, traders, and analysts to react instantly to earnings, M&A, and other market‑moving events.
Funding
€1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Investment professionals need immediate access to market-moving news, but traditional financial news services often deliver alerts with seconds‑to‑minutes latency and lack granular, AI‑enhanced analysis, causing missed trading opportunities and inefficient research.
Solution
Financial News Systems provides a real-time news platform that delivers alerts within milliseconds of a press release. The service covers over 9,000 publicly traded companies across Europe, Canada, and the U.S., automatically extracting key metrics, consensus estimates, and other relevant data. AI algorithms generate concise summaries and highlight the significance of each event, such as earnings beats, guidance changes, M&A announcements, and drug trial results. Users can filter the feed by company, date, or country and drill into detailed analysis that includes original source documents and FactSet consensus comparisons. An integrated earnings calendar helps professionals plan and react to upcoming releases, all through a single, low‑latency interface.
Target Audience
Primary customers are portfolio managers, traders, and research analysts at hedge funds, asset management firms, and proprietary trading desks who require ultra‑fast, data‑rich news for decision‑making.
Features
- Millisecond‑level timestamps for every news alert, ensuring sub‑second delivery
- Coverage of 9,000+ companies with multi‑country (Europe, Canada, U.S.) scope
- AI‑driven summaries and automatic extraction of financial metrics, consensus estimates, and deal values
- Real‑time comparison of earnings results against FactSet estimates, indicating beats or misses
- Dedicated sections for M&A, pharmaceutical trial outcomes, SEC filings, rights issues, and analyst research
- Interactive earnings calendar with date, company, and country filters
- Direct links to original source documents for verification and deeper research